Health provider Simplyhealth has invested a majority stake in eyecare startup OcuPlan, which allows personalised management for patients.

The company said that the deal will enable expansion into innovative treatment and funding for conditions such as glaucoma, ocular hypertension, age-related macular degeneration and diabetic retinopathy.

This is in alignment with aims to reduce strain on NHS services and allow affordable healthcare for all.

Dr Sneh Khemka, CEO of Simplyhealth, said: ‘As a former ophthalmic surgeon myself, I know that OcuPlan’s technology can empower people with long-term eye conditions to take control of their treatment and their health. It can also really help to take the strain off the NHS, and I couldn’t be prouder to make OcuPlan our first investment as CEO.’

Dan Calladine, founder & CEO of OcuPlan, commented: ‘Simplyhealth shares our belief in the value of preventative healthcare; joining its ecosystem means we can expand our offering to more people with long-term eye problems who want to see their chosen specialist in an affordable way.’

Founded in 2019, OcuPlan allows patients to choose their own eye specialists and eyecare products and has a network of over 500 optometrists and ophthalmologists, with payment plans for those in need of specialist eye care.